Circulating Tumour Necrosis Factor-Alpha and Interleukin-6 in Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis
Sriwijaya Journal of Neurology · 21.07.2026 · 4 (1) · 11-19
DOI: 10.59345/sjn.v4i1.289 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Sriwijaya Journal of Neurology, online erschienen am 21.07.2026. Verfasst von Deviana Christanty und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Chronic low-grade inflammation is increasingly implicated in diabetic peripheral neuropathy (DPN). Tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) have been proposed as circulating correlates of nerve injury, yet the evidence is inconsistent, a previous synthesis addressed TNF-α alone, and no pooled estimate has ever been reported for IL-6.
Objective
To determine whether circulating TNF-α and IL-6 concentrations differ between diabetic patients with and without peripheral neuropathy, and to quantify the magnitude, precision, and consistency of any difference.
Methods
Four databases were searched for observational studies reporting serum or plasma TNF-α and/or IL-6 in diabetic patients with versus without neuropathy. Standardised mean differences (SMD, Hedges g) were pooled using a random-effects model, with Hartung–Knapp adjustment, restricted maximum-likelihood re-estimation, cluster-collapsed and leave-one-out analyses, and a prediction interval. Risk of bias used the Newcastle–Ottawa Scale and certainty the GRADE framework.
Results
Four studies (476 participants; 249 with DPN, 227 without) provided seven cytokine comparisons. The overall SMD was 0.70 (95% CI 0.22–1.18; p = 0.005; I² = 91%), robust across all sensitivity analyses. The effect was driven by IL-6, which was significantly and homogeneously elevated (SMD 0.65, 95% CI 0.42–0.87; I² = 2%). Pooled TNF-α was higher but non-significant and heterogeneous (SMD 0.71, 95% CI −0.18–1.60; I² = 95%), owing to one statin-treated cohort; excluding it raised the estimate to 0.88. Certainty was low for IL-6 and very low for TNF-α.
Conclusion
DPN is associated with higher circulating pro-inflammatory cytokines, with IL-6 the most consistent correlate and the first for which a pooled estimate is available. IL-6 merits prospective evaluation as a biomarker of neuropathy risk. Findings are hypothesis-generating.
Zitieren
APA
Christanty, D., Widyadharma, I. P. E., & Meidiary, A. A. A. (2026). Circulating Tumour Necrosis Factor-Alpha and Interleukin-6 in Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Sriwijaya Journal of Neurology, 4(1), 11-19. https://doi.org/10.59345/sjn.v4i1.289
Vancouver
Christanty D, Widyadharma IPE, Meidiary AAA. Circulating Tumour Necrosis Factor-Alpha and Interleukin-6 in Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Sriwijaya Journal of Neurology. 2026;4(1):11-19. doi:10.59345/sjn.v4i1.289
BibTeX
@article{Christanty2026,
author = {Christanty, Deviana and Widyadharma, I Putu Eka and Meidiary, Anak Agung Ayu},
title = {Circulating Tumour Necrosis Factor-Alpha and Interleukin-6 in Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis},
journal = {Sriwijaya Journal of Neurology},
year = {2026},
volume = {4},
number = {1},
pages = {11--19},
doi = {10.59345/sjn.v4i1.289}
}
EUVIMED